Literature DB >> 21685248

Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1α (HIF1A) and result in differential HIF1A-dependent gene expression.

Jonathan Jantsch1, Melanie Wiese, Johannes Schödel, Kirstin Castiglione, Joachim Gläsner, Sophie Kolbe, David Mole, Ulrike Schleicher, Kai-Uwe Eckardt, Michael Hensel, Roland Lang, Christian Bogdan, Markus Schnare, Carsten Willam.   

Abstract

HIF1A is a transcription factor that plays a central role for the adaptation to tissue hypoxia and for the inflammatory response of myeloid cells, including DCs. HIF1A is stabilized by hypoxia but also by TLR ligands under normoxic conditions. The underlying signaling events leading to the accumulation of HIF1A in the presence of oxygen are still poorly understood. Here, we show that in contrast to hypoxic stabilization of HIF1A, normoxic, TLR-mediated HIF1A accumulation in DCs follows a different pathway that predominantly requires MYD88-dependent NF-κB activity. The TLR-induced HIF1A controls a subset of proinflammatory genes that are insufficiently induced following hypoxia-mediated HIF1A induction. Thus, TLR activation and hypoxia stabilize HIF1A via distinct signaling pathways, resulting in differential HIF1A-dependent gene expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685248     DOI: 10.1189/jlb.1210683

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  38 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

3.  The virtues of oxygenation: low tissue oxygen adversely affects the killing of Leishmania.

Authors:  Lopa M Das; Kurt Q Lu
Journal:  J Invest Dermatol       Date:  2014-09       Impact factor: 8.551

4.  Hypoxia-inducible factor-1α and its role in the proliferation of retinoblastoma cells.

Authors:  Bruno F Fernandes; James Coates; Alexandre N Odashiro; Carlos Quezada; Aimee Huynh; Patricia R Odashiro; Macanori Odashiro; Miguel N Burnier
Journal:  Pathol Oncol Res       Date:  2013-12-14       Impact factor: 3.201

5.  Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.

Authors:  Valentin Schatz; Yannic Strüssmann; Alexander Mahnke; Gunnar Schley; Maximilian Waldner; Uwe Ritter; Jens Wild; Carsten Willam; Nathalie Dehne; Bernhard Brüne; Jennifer M McNiff; Oscar R Colegio; Christian Bogdan; Jonathan Jantsch
Journal:  J Immunol       Date:  2016-10-17       Impact factor: 5.422

Review 6.  Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Sofia Konisti; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

7.  Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages.

Authors:  Alexander Mahnke; Robert J Meier; Valentin Schatz; Julian Hofmann; Kirstin Castiglione; Ulrike Schleicher; Otto S Wolfbeis; Christian Bogdan; Jonathan Jantsch
Journal:  J Invest Dermatol       Date:  2014-02-28       Impact factor: 8.551

8.  Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing.

Authors:  Christopher Scott; James Bonner; Danqing Min; Philip Boughton; Rebecca Stokes; Kuan Minn Cha; Stacey N Walters; Kendle Maslowski; Frederic Sierro; Shane T Grey; Stephen Twigg; Susan McLennan; Jenny E Gunton
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-02       Impact factor: 4.249

9.  HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination.

Authors:  Tamara Bhandari; Joshua Olson; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

Review 10.  The ever-expanding role of HIF in tumour and stromal biology.

Authors:  Edward L LaGory; Amato J Giaccia
Journal:  Nat Cell Biol       Date:  2016-04       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.